Last reviewed · How we verify
Palonosetron, Dexamethasone, Carboplatin, Paclitaxel, Olanzapine
Palonosetron, Dexamethasone, Carboplatin, Paclitaxel, Olanzapine is a Small molecule drug developed by Fondazione IRCCS Istituto Nazionale dei Tumori, Milano. It is currently in Phase 2 development.
At a glance
| Generic name | Palonosetron, Dexamethasone, Carboplatin, Paclitaxel, Olanzapine |
|---|---|
| Sponsor | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Olanzapine Against Delayed Nausea and Vomiting in Women Receiving Carboplatin Plus Paclitaxel (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Palonosetron, Dexamethasone, Carboplatin, Paclitaxel, Olanzapine CI brief — competitive landscape report
- Palonosetron, Dexamethasone, Carboplatin, Paclitaxel, Olanzapine updates RSS · CI watch RSS
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano portfolio CI
Frequently asked questions about Palonosetron, Dexamethasone, Carboplatin, Paclitaxel, Olanzapine
What is Palonosetron, Dexamethasone, Carboplatin, Paclitaxel, Olanzapine?
Palonosetron, Dexamethasone, Carboplatin, Paclitaxel, Olanzapine is a Small molecule drug developed by Fondazione IRCCS Istituto Nazionale dei Tumori, Milano.
Who makes Palonosetron, Dexamethasone, Carboplatin, Paclitaxel, Olanzapine?
Palonosetron, Dexamethasone, Carboplatin, Paclitaxel, Olanzapine is developed by Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (see full Fondazione IRCCS Istituto Nazionale dei Tumori, Milano pipeline at /company/fondazione-irccs-istituto-nazionale-dei-tumori-milano).
What development phase is Palonosetron, Dexamethasone, Carboplatin, Paclitaxel, Olanzapine in?
Palonosetron, Dexamethasone, Carboplatin, Paclitaxel, Olanzapine is in Phase 2.